Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Enzo Biochem, Inc. (OTCMKTS: ENZB) to Battery Ventures for $0.70 per share in cash is fair to Enzo shareholders.

Enzo Biochem (OTC:ENZB) announced a merger agreement to be acquired by Battery Ventures, a global technology investment firm, ...

Transaction Follows Completion of Comprehensive Strategic Review by Special Committee of the Board to Maximize Shareholder ...